The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients
Descarga: The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients Archivo: covid-19/The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients. BLOOD.pdf The BTK-inhibitor ibrutinib is used to treat indolent B-cell malignancies and chronic graft versus host disease. The potential for ibrutinib to abrogate pulmonary inflammatory cytokines, lung injury and…
